SWOG clinical trial number
SWOG-8792 (INT-0079) (EST-2886)
Phase III Study of Interferon Alfa-nl (Wellferon®) as Adjuvant Treatment for Resectable Renal Cell Carcinoma
Closed
Phase
Published
Abbreviated Title
Phase III Study of Interferon Alfa-nl (Wellferon®) as Adjuvant Treatment for Resectable Renal Cell Carcinoma
Activated
06/15/1987
Closed
04/08/1992
Publication Information Expand/Collapse
2003
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial